Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wallemacq

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Plos One|June 5, 2013
Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosisFrançois Huaux, Sabrina Noel, Barbara Dhooghe, et al.
Therapeutic Drug Monitoring|March 5, 2009
Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assayPierre Wallemacq, Jean-Sebastien Goffinet, Susan O'Morchoe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 15, 2015
First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemiaArnaud Capron, Marina Venzon Antunes, Sandrine Comparsi Wagner, et al.
Clinical Chemistry|May 21, 2015
Application of the characteristic function to evaluate and compare analytical variability in an external quality assessment scheme for serum ethanolWim Coucke, Corine Charlier, Willy Lambert, et al.
Kidney International Reports|August 11, 2020
Prevalence and Risk Factors of CKD in South Kivu, Democratic Republic of Congo: A Large-Scale Population StudyMannix Imani Masimango, Ernest Kiswaya Sumaili, Pierre Wallemacq, et al.
Therapeutic Drug Monitoring|July 11, 2012
Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapyMarina V Antunes, Rafael Linden, Tamyris V Santos, et al.
BMC Nephrology|June 26, 2021
Impact of rural versus urban setting on kidney markers: a cross-sectional study in South-Kivu, DRCongoMannix Imani Masimango, Michel P Hermans, Espoir Bwenge Malembaka, et al.
Therapeutic Drug Monitoring|March 11, 2010
Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assayPierre Wallemacq, Gregory T Maine, Keith Berg, et al.
The American Journal of Cardiology|February 5, 2013
Value of adding natriuretic peptides and electrocardiographic findings to assess the presence of cardiac dysfunction in patients ≥80 years of ageBert Vaes, Benoit Boland, Christophe Scavée, et al.
Therapeutic Drug Monitoring|September 21, 2013
Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelinesLaure Elens, Arnaud Capron, Ron H N van Schaik, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Plos One|June 5, 2013
Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosisFrançois Huaux, Sabrina Noel, Barbara Dhooghe, et al.
Therapeutic Drug Monitoring|March 5, 2009
Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assayPierre Wallemacq, Jean-Sebastien Goffinet, Susan O'Morchoe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 15, 2015
First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemiaArnaud Capron, Marina Venzon Antunes, Sandrine Comparsi Wagner, et al.
Clinical Chemistry|May 21, 2015
Application of the characteristic function to evaluate and compare analytical variability in an external quality assessment scheme for serum ethanolWim Coucke, Corine Charlier, Willy Lambert, et al.
Kidney International Reports|August 11, 2020
Prevalence and Risk Factors of CKD in South Kivu, Democratic Republic of Congo: A Large-Scale Population StudyMannix Imani Masimango, Ernest Kiswaya Sumaili, Pierre Wallemacq, et al.
Therapeutic Drug Monitoring|July 11, 2012
Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapyMarina V Antunes, Rafael Linden, Tamyris V Santos, et al.
BMC Nephrology|June 26, 2021
Impact of rural versus urban setting on kidney markers: a cross-sectional study in South-Kivu, DRCongoMannix Imani Masimango, Michel P Hermans, Espoir Bwenge Malembaka, et al.
Therapeutic Drug Monitoring|March 11, 2010
Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assayPierre Wallemacq, Gregory T Maine, Keith Berg, et al.
The American Journal of Cardiology|February 5, 2013
Value of adding natriuretic peptides and electrocardiographic findings to assess the presence of cardiac dysfunction in patients ≥80 years of ageBert Vaes, Benoit Boland, Christophe Scavée, et al.
Therapeutic Drug Monitoring|September 21, 2013
Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelinesLaure Elens, Arnaud Capron, Ron H N van Schaik, et al.
Pageof 14